David Hinton
Director of Finance/CFO chez EMPIRED LIMITED
Profil
David Hinton is currently serving as the Chief Financial Officer, Secretary & Director at Empired Ltd.
He is also a Director at Royal Perth Yacht Club, a Non-Executive Director at HeraMED Ltd., a Director at The Australia Day Council WA, Inc., and a Non-Executive Director at Valo Therapeutics Oy.
In addition, he is an Associate & Member of Governance Institute of Australia Ltd.
Mr. Hinton has previously worked as the CFO, Secretary & Investor Relations Person at Amcom Pty Ltd.
and as the Group Financial Controller at Elders Ltd.
Postes actifs de David Hinton
| Sociétés | Poste | Début |
|---|---|---|
| EMPIRED LIMITED | Director of Finance/CFO | 02/05/2016 |
| HERAMED LIMITED | Director/Board Member | 21/08/2018 |
Governance Institute of Australia Ltd.
 Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019. | Corporate Officer/Principal | 01/01/1994 |
| The Australia Day Council WA, Inc. | Director/Board Member | 01/10/2017 |
| Royal Perth Yacht Club | Director/Board Member | - |
Valo Therapeutics Oy
 Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020. | Director/Board Member | 01/01/2021 |
Anciens postes connus de David Hinton
| Sociétés | Poste | Fin |
|---|---|---|
| ELDERS LIMITED | Comptroller/Controller/Auditor | - |
| AMCOM TELECOMMUNICATIONS LIMITED | Director of Finance/CFO | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ELDERS LIMITED | Process Industries |
| HERAMED LIMITED | Technology Services |
| Entreprise privées | 6 |
|---|---|
Amcom Pty Ltd.
 Amcom Pty Ltd. Specialty TelecommunicationsCommunications Amcom Pty Ltd. provides data connectivity and telecommunications services. The company was founded by Andrew McLean on August 19, 1988 and is headquartered in Melbourne, Australia. | Communications |
Empired Ltd.
 Empired Ltd. Miscellaneous Commercial ServicesCommercial Services Empired Ltd. engages in the provision of information technology services and solutions. It works with organizations to empower staff, streamline and automate business processes. The company offers cloud, customer relationship management, data insights & business intelligence, digital, enterprise content management, and enterprise resource planning services. Empired operates its business through the following geographical locations: Australia, New Zealand and North America. The company was founded in 1999 and is headquartered in Perth, Australia. | Commercial Services |
| Royal Perth Yacht Club | |
Governance Institute of Australia Ltd.
Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019. | Commercial Services |
| The Australia Day Council WA, Inc. | |
Valo Therapeutics Oy
Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020. | Health Technology |
